Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.

MLA

Pilch, B., et al. “Specific Inhibition of Serine- and Arginine-Rich Splicing Factors Phosphorylation, Spliceosome Assembly, and Splicing by the Antitumor Drug NB-506.” Cancer Research, vol. 61, no. 18, Sept. 2001, pp. 6876–84. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=11559564&authtype=sso&custid=ns315887.

APA

Pilch, B., Allemand, E., Facompré, M., Bailly, C., Riou, J. F., Soret, J., & Tazi, J. (2001). Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506. Cancer Research, 61(18), 6876–6884.

Chicago

Pilch, B, E Allemand, M Facompré, C Bailly, J F Riou, J Soret, and J Tazi. 2001. “Specific Inhibition of Serine- and Arginine-Rich Splicing Factors Phosphorylation, Spliceosome Assembly, and Splicing by the Antitumor Drug NB-506.” Cancer Research 61 (18): 6876–84. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=11559564&authtype=sso&custid=ns315887.